137 related articles for article (PubMed ID: 36739697)
1. Rho-kinase inhibitor restores glomerular fatty acid metabolism in diabetic kidney disease.
Nagai Y; Matoba K; Yako H; Ohashi S; Sekiguchi K; Mitsuyoshi E; Sango K; Kawanami D; Utsunomiya K; Nishimura R
Biochem Biophys Res Commun; 2023 Mar; 649():32-38. PubMed ID: 36739697
[TBL] [Abstract][Full Text] [Related]
2. Rho-associated, coiled-coil-containing protein kinase 1 regulates development of diabetic kidney disease via modulation of fatty acid metabolism.
Nagai Y; Matoba K; Takeda Y; Yako H; Akamine T; Sekiguchi K; Kanazawa Y; Yokota T; Sango K; Kawanami D; Utsunomiya K; Nishimura R
Kidney Int; 2022 Sep; 102(3):536-545. PubMed ID: 35597365
[TBL] [Abstract][Full Text] [Related]
3. Targeting of RhoA/ROCK signaling ameliorates progression of diabetic nephropathy independent of glucose control.
Kolavennu V; Zeng L; Peng H; Wang Y; Danesh FR
Diabetes; 2008 Mar; 57(3):714-23. PubMed ID: 18083785
[TBL] [Abstract][Full Text] [Related]
4. The RhoA/ROCK Pathway Ameliorates Adhesion and Inflammatory Infiltration Induced by AGEs in Glomerular Endothelial Cells.
Rao J; Ye Z; Tang H; Wang C; Peng H; Lai W; Li Y; Huang W; Lou T
Sci Rep; 2017 Jan; 7():39727. PubMed ID: 28054559
[TBL] [Abstract][Full Text] [Related]
5. Rho-kinase inhibition prevents the progression of diabetic nephropathy by downregulating hypoxia-inducible factor 1α.
Matoba K; Kawanami D; Okada R; Tsukamoto M; Kinoshita J; Ito T; Ishizawa S; Kanazawa Y; Yokota T; Murai N; Matsufuji S; Takahashi-Fujigasaki J; Utsunomiya K
Kidney Int; 2013 Sep; 84(3):545-54. PubMed ID: 23615507
[TBL] [Abstract][Full Text] [Related]
6. Deciphering Rho-associated, coiled-coil-containing protein kinase in diabetic nephropathy: small steps towards a giant leap.
Matoba K
Endocr J; 2023 Aug; 70(8):771-776. PubMed ID: 37468263
[TBL] [Abstract][Full Text] [Related]
7. ROCK1 inhibition improves wound healing in diabetes via RIPK4/AMPK pathway.
Huyan T; Fan L; Zheng ZY; Zhao JH; Han ZR; Wu P; Ma Q; Du YQ; Shi YD; Gu CY; Li XJ; Wang WH; Zhang L; Tie L
Acta Pharmacol Sin; 2024 Jul; 45(7):1477-1491. PubMed ID: 38538716
[TBL] [Abstract][Full Text] [Related]
8. ROCK2 regulates TGF-β-induced expression of CTGF and profibrotic genes via NF-κB and cytoskeleton dynamics in mesangial cells.
Nagai Y; Matoba K; Kawanami D; Takeda Y; Akamine T; Ishizawa S; Kanazawa Y; Yokota T; Utsunomiya K; Nishimura R
Am J Physiol Renal Physiol; 2019 Oct; 317(4):F839-F851. PubMed ID: 31364374
[TBL] [Abstract][Full Text] [Related]
9. ROCK1 Induces Endothelial-to-Mesenchymal Transition in Glomeruli to Aggravate Albuminuria in Diabetic Nephropathy.
Peng H; Li Y; Wang C; Zhang J; Chen Y; Chen W; Cao J; Wang Y; Hu Z; Lou T
Sci Rep; 2016 Feb; 6():20304. PubMed ID: 26842599
[TBL] [Abstract][Full Text] [Related]
10. The Rho kinase inhibitor, fasudil, ameliorates diabetes-induced cardiac dysfunction by improving calcium clearance and actin remodeling.
Lai D; Gao J; Bi X; He H; Shi X; Weng S; Chen Y; Yang Y; Ye Y; Fu G
J Mol Med (Berl); 2017 Feb; 95(2):155-165. PubMed ID: 27576917
[TBL] [Abstract][Full Text] [Related]
11. The Rho-kinase inhibitor, fasudil, attenuates diabetic nephropathy in streptozotocin-induced diabetic rats.
Gojo A; Utsunomiya K; Taniguchi K; Yokota T; Ishizawa S; Kanazawa Y; Kurata H; Tajima N
Eur J Pharmacol; 2007 Jul; 568(1-3):242-7. PubMed ID: 17511984
[TBL] [Abstract][Full Text] [Related]
12. Rho-Kinase Blockade Attenuates Podocyte Apoptosis by Inhibiting the Notch Signaling Pathway in Diabetic Nephropathy.
Matoba K; Kawanami D; Nagai Y; Takeda Y; Akamine T; Ishizawa S; Kanazawa Y; Yokota T; Utsunomiya K
Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28820432
[TBL] [Abstract][Full Text] [Related]
13. Simvastatin alleviates hyperpermeability of glomerular endothelial cells in early-stage diabetic nephropathy by inhibition of RhoA/ROCK1.
Peng H; Luo P; Li Y; Wang C; Liu X; Ye Z; Li C; Lou T
PLoS One; 2013; 8(11):e80009. PubMed ID: 24244596
[TBL] [Abstract][Full Text] [Related]
14. The influence of fasudil on the epithelial-mesenchymal transdifferentiation of renal tubular epithelial cells from diabetic rats.
Wu G; Tu Y; Jia R
Biomed Pharmacother; 2010 Feb; 64(2):124-9. PubMed ID: 20006464
[TBL] [Abstract][Full Text] [Related]
15. Chronic Rho-kinase inhibition improves left ventricular contractile dysfunction in early type-1 diabetes by increasing myosin cross-bridge extension.
Waddingham MT; Edgley AJ; Astolfo A; Inagaki T; Fujii Y; Du CK; Zhan DY; Tsuchimochi H; Yagi N; Kelly DJ; Shirai M; Pearson JT
Cardiovasc Diabetol; 2015 Jul; 14():92. PubMed ID: 26194354
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of the Rho/ROCK pathway enhances the efficacy of cisplatin through the blockage of hypoxia-inducible factor-1α in human ovarian cancer cells.
Ohta T; Takahashi T; Shibuya T; Amita M; Henmi N; Takahashi K; Kurachi H
Cancer Biol Ther; 2012 Jan; 13(1):25-33. PubMed ID: 22336585
[TBL] [Abstract][Full Text] [Related]
17. Rho-Kinase inhibitor fasudil suppresses high glucose-induced H9c2 cell apoptosis through activation of autophagy.
Gao H; Hou F; Dong R; Wang Z; Zhao C; Tang W; Wu Y
Cardiovasc Ther; 2016 Oct; 34(5):352-9. PubMed ID: 27333569
[TBL] [Abstract][Full Text] [Related]
18. The Rho-kinase inhibitor fasudil restores normal motor nerve conduction velocity in diabetic rats by assuring the proper localization of adhesion-related molecules in myelinating Schwann cells.
Kanazawa Y; Takahashi-Fujigasaki J; Ishizawa S; Takabayashi N; Ishibashi K; Matoba K; Kawanami D; Yokota T; Tajima N; Utsunomiya K
Exp Neurol; 2013 Sep; 247():438-46. PubMed ID: 23337773
[TBL] [Abstract][Full Text] [Related]
19. Rho kinase inhibition in diabetic nephropathy.
Komers R
Curr Opin Nephrol Hypertens; 2011 Jan; 20(1):77-83. PubMed ID: 21076299
[TBL] [Abstract][Full Text] [Related]
20. Fasudil ameliorates endothelial dysfunction in streptozotocin-induced diabetic rats: a possible role of Rho kinase.
Hofni A; Shehata Messiha BA; Mangoura SA
Naunyn Schmiedebergs Arch Pharmacol; 2017 Aug; 390(8):801-811. PubMed ID: 28493050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
